+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

High titer serum anti tubulin antibodies are a marker for chronic inflammatory demyelinating polyneuropathy cidp



High titer serum anti tubulin antibodies are a marker for chronic inflammatory demyelinating polyneuropathy cidp



Neurology 42(4 Suppl. 3): 409




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 031695691

Download citation: RISBibTeXText


Related references

High-titer selective serum anti-beta-tubulin antibodies in chronic inflammatory demyelinating polyneuropathy. Neurology 43(3 Pt 1): 557-562, 1993

Anti-GM1 antibodies in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) treated with intravenous immunoglobulin (IVIg). Journal of Neuroimmunology 54(1-2): 109-115, 1994

Anti-beta-tubulin antibodies in patients with chronic inflammatory demyelinating polyneuropathy. Journal of Neuroimmunology 54(1-2): 194, 1994

Chronic inflammatory demyelinating polyneuropathy (CIDP) with ophthalmoplegia: a case with asymmetric limb weakness and high titers of anti-GM1 antibody. European Journal of Neurology 3(5): 457-461, 1996

Anti-beta-tubulin antibodies have no diagnostic value in patients with chronic inflammatory demyelinating polyneuropathy. Journal of Neurology 242(9): 599-603, 1995

Clinical and electrophysiological characteristics of chronic inflammatory demyelinating polyneuropathy , CIDP with monoclonal gammopathy of uncertain significance and demyelinating neuropathy with antibodies to myelin associated glycoprotein. Neurology 50(4 Suppl. 4): A145, 1998

Chronic inflammatory demyelinating polyneuropathy with high titer of anti-sulfated glucuronyl paragloboside antibody. Muscle and Nerve 21(5): 682-683, 1998

The 301 to 314 amino acid residue of beta-tubulin is not a target epitope for serum IgM antibodies in chronic inflammatory demyelinating polyneuropathy. Journal of the Neurological Sciences 163(1): 44-46, 1999

Chronic inflammatory demyelinating polyneuropathy (CIDP): change of serum IgG dimer levels during treatment with intravenous immunoglobulins. Journal of Neuroinflammation 12: 148, 2015

High dose intravenous immunoglobulin ivig in the treatment of chronic inflammatory demyelinating polyneuropathy cidp. Annals of Allergy 64(1): 81, 1990

Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. Journal of the Neurological Sciences 114(1): 49-55, 1993

Treatment of childhood chronic inflammatory demyelinating polyneuropathy cidp with high dose intravenous gamma globulin ivig. Neurology 40(4 Suppl. 1): 362, 1990

High-titer immunoglobulin M antibody to nerve-specific class III beta-tubulin in the serum of a patient with sensory demyelinating polyneuropathy. Muscle and Nerve 19(12): 1638-1639, 1996

Can electrophysiology differentiate polyneuropathy with anti-MAG/SGPG antibodies from chronic inflammatory demyelinating polyneuropathy?. Clinical Neurophysiology 113(3): 346-353, 2002

Neurophysiologic differential diagnosis between polyneuropathy with anti-MAG antibodies and chronic inflammatory demyelinating polyneuropathy. 2007